Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

GSK (GSK) plc announced that the U.S. Food and Drug Administration has approved a 200 mg/mL autoinjector of Benlysta, a B-lymphocyte ...

The skin manifestation, known as lupus rash, often comes with persistent itching, which can lead to scarring and hair loss. This can significantly impact the physical, ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

Circular rashes may be puzzling—and alarming. The instant most individuals catch sight of a circle or ring-shaped area on the ...

The median time of vitamin K1 cream treatment was 24 weeks (range 6-28); the oral tetracyclines therapy was associated in 13 (39.4%) pts. The decrease in skin rash to grade 1-0 was observed in 12 ...

First off, let's talk about those lupus rashes. While most folks might get that classic "butterfly" rash on their face, it's more likely to pop up on the scalp and ears in Black patients. Lupus ...

The oral TLR 7/8 inhibitor showed clinically meaningful improvement in disease activity for patients with active lupus rash in a phase 2 study. This site is intended for healthcare professionals .

Long-term control of cardiovascular risk factors and sustained clinical remission help to mitigate the higher risk for atherosclerosis progression in patients with lupus.

Other common symptoms of lupus include fatigue, hair loss, sun sensitivity, fever, skin rashes, kidney problems, swelling of blood vessels, and ulcers (CDC). It is known as ‘the great imitator’ ...